The medial prefrontal cortex determines the accumbens dopamine response to stress through the opposing influences of norepinephrine and dopamine

Cerebral Cortex

Volumn 17, Issue 12, 2007, Pages 2796-2804

  Pascucci, Tiziana ^a,b   Ventura, Rossella ^b,c   Latagliata, Emanuele Claudio ^a,b   Cabib, Simona ^a,b   Puglisi Allegra, Stefano ^a,b  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b IRCCS FONDAZIONE SANTA LUCIA   (Italy)

^c UNIVERSITY OF L'AQUILA   (Italy)

Author keywords

Appraisal; Coping; Dopamine; Medial prefrontal cortex; Norepinephrine; Nucleus accumbens

Indexed keywords

DESIPRAMINE; DOPAMINE; NORADRENALIN; OXIDOPAMINE; VANOXERINE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG INHIBITION; MALE; MICRODIALYSIS; NONHUMAN; NUCLEUS ACCUMBENS; PREFRONTAL CORTEX; PRIORITY JOURNAL; RAT; STATISTICAL ANALYSIS;

ANIMALS; DOPAMINE; MALE; NEUROTRANSMITTER AGENTS; NOREPINEPHRINE; NUCLEUS ACCUMBENS; PREFRONTAL CORTEX; RATS; RATS, SPRAGUE-DAWLEY; STRESS; SYNAPTIC TRANSMISSION;

EID: 36248987227     PISSN: 10473211     EISSN: 14602199     Source Type: Journal    
DOI: 10.1093/cercor/bhm008     Document Type: Article

References (81)

1. Abercrombie ED, Zigmond MJ. 1989. Partial injury to central noradrenergic neurons: reduction of tissue norepinephrine content is greater than reduction of extracellular norepinephrine measured by microdialysis. J Neurosci. 9:4062-4067.
2. Amat J, Baratta MV, Paul E, Bland ST, Watkins LR, Maier SF. 2005. Medial prefrontal cortex determines how stressor controllability affects behavior and dorsal raphe nucleus. Nat Neurosci. 8:365-371.
3. Bland ST, Hargrave D, Pepin JL, Amat J, Watkins LR, Maier SF. 2003. Stressor controllability modulates stress-induced dopamine and serotonin efflux and morphine-induced serotonin efflux in the medial prefrontal cortex. Neuropsychopharmacology. 28:1589-1596.
4. Bland ST, Twining C, Watkins LR, Maier SF. 2003. Stressor controllability modulates stress-induced serotonin but not dopamine efflux in the nucleus accumbens shell. Synapse. 49:206-208.
5. Bonne O, Grillon C, Vythilingam M, Neumeister A, Charney DS. 2004. Adaptive and maladaptive psychobiological responses to severe psychological stress: implications for the discovery of novel pharmacotherapy. Neurosci Biobehav Rev. 28:65-94.
6. Brady KT, Sinha R. 2005. Co-occurring mental and substance use disorders: the neurobiological effects of chronic stress. Am J Psychiatry. 162:1483-1493.
7. Cabib S, D'Amato FR, Puglisi-Allegra S, Maestripieri D. 2000. Behavioral and mesocorticolimbic dopamine responses to non aggressive social interactions depend on previous social experiences and on the opponent's sex. Behav Brain Res. 112:13-22.
8. Cabib S, Kempf E, Schleef C, Oliverio A, Puglisi-Allegra S. 1988. Effects of immobilization stress on dopamine and its metabolites in different brain areas of the mouse: role of genotype and stress duration. Brain Res. 441:153-160.
9. Cabib S, Puglisi-Allegra S. 1994. Opposite responses of mesolimbic dopamine system to controllable and uncontrollable aversive experiences. J Neurosci. 14:3333-3340.
10. Cabib S, Puglisi-Allegra S. 1996. Stress, depression and the mesolimbic dopamine system. Psychopharmacology (Berl). 128:331-342.
11. Cabib S, Puglisi-Allegra S, Oliverio A. 1984. Chronic stress enhances apomorphine-induced stereotyped behavior in mice: involvement of endogenous opioids. Brain Res. 298:138-140.
12. Cabib S, Ventura R, Puglisi-Allegra S. 2002. Opposite imbalances between mesocortical and mesoaccumbens dopamine responses to stress by the same genotype depending on living conditions. Behav Brain Res. 129:179-185.
13. Carboni E, Silvagni A, Vacca C, Chiara G. 2006. Cumulative effect of norepinephrine and dopamine carrier blockade on extracellular dopamine increase in the nucleus accumbens shell, bed nucleus of stria terminalis and prefrontal cortex. J Neurochem. 96:473-481.
14. Cardinal RN, Everitt BJ. 2004. Neural and psychological mechanisms underlying appetitive learning: links to drug addiction. Curr Opin Neurobiol. 14:156-162.
15. Cardinal RN, Parkinson JA, Hall J, Everitt BJ. 2002. Emotion and motivation: the role of the amygdala, ventral striatum, and prefrontal cortex. Neurosci Biobehav Rev. 26:321-352.
16. Carr DB, O'Donnell P, Card JP, Sesack SR. 1999. Dopamine terminals in the rat prefrontal cortex synapse on pyramidal cells that project to the nucleus accumbens. J Neurosci. 19:11049-11060.
17. Carr DB, Sesack SR. 2000. Projections from the rat prefrontal cortex to the ventral tegmental area: target specificity in the synaptic associations with mesoaccumbens and mesocortical neurons. J Neurosci. 20:3864-3873.
18. Charney DS. 2004. Psychobiological mechanisms of resilience and vulnerability: implications for successful adaptation to extreme stress. Am J Psychiatry. 161:195-216.
19. Chrapusta SJ, Wyatt RJ, Masserano JM. 1997. Effects of single and repeated footshock on dopamine release and metabolism in the brains of Fischer rats. J Neurochem. 68:2024-2031.
20. D'Angio M, Serrano A, Driscoll P, Scatton B. 1988. Stressful environmental stimuli increase extracellular DOPAC levels in the prefrontal cortex of hypoemotional (Roman high-avoidance) but not hyperemotional (Roman low-avoidance) rats. An in vivo voltammetric study. Brain Res. 451:237-247.
21. Dailly E, Chenu F, Renard CE, Bourin M. 2004. Dopamine, depression and antidepressants. Fundam Clin Pharmacol. 18:601-607.
22. Dalley JW, Cardinal RN, Robbins TW. 2004. Prefrontal executive and cognitive functions in rodents: neural and neurochemical substrates. Neurosci Biobehav Rev. 28:771-784.
23. Dalley JW, Mason K, Stanford SC. 1996. Increased levels of extracellular noradrenaline in the frontal cortex of rats exposed to naturalistic environmental stimuli: modulation by acute systemic administration of diazepam or buspirone. Psychopharmacology (Berl). 127:47-54.
24. Darracq L, Blanc G, Glowinski J, Tassin JP. 1998. Importance of the noradrenaline-dopamine coupling in the locomotor activating effects of D-amphetamine. J Neurosci. 18:2729-2739.
25. Deutch AY, Clark WA, Roth RH. 1990. Prefrontal cortical dopamine depletion enhances the responsiveness of mesolimbic dopamine neurons to stress. Brain Res. 521:311-315.
26. Devoto P, Flore G, Saba P, Fa M, Gessa GL. 2005. Stimulation of the locus coeruleus elicits noradrenaline and dopamine release in the medial prefrontal and parietal cortex. J Neurochem. 92:368-374.
27. Diana M, Pistis M, Carboni S, Gessa GL, Rossetti ZL. 1993. Profound decrement of mesolimbic dopaminergic neuronal activity during ethanol withdrawal syndrome in rats: electrophysiological and biochemical evidence. Proc Natl Acad Sci USA. 90:7966-7969.
28. Di Chiara G. 2002. Nucleus accumbens shell and core dopamine: differential role in behavior and addiction. Behav Brain Res. 137:75-114.
29. Doherty MD, Gratton A. 1996. Medial prefrontal cortical D1 receptor modulation of the meso-accumbens dopamine response to stress: an electrochemical study in freely-behaving rats. Brain Res. 715:86-97.
30. Everitt BJ, Wolf ME. 2002. Psychomotor stimulant addiction: a neural systems perspective. J Neurosci. 22:3312-3320.
31. Feenstra MG, Botterblom MH. 1996. Rapid sampling of extracellular dopamine in the rat prefrontal cortex during food consumption, handling and exposure to novelty. Brain Res. 742:17-24.
32. Feenstra MG, Botterblom MH, Mastenbroek S. 2000. Dopamine and noradrenaline efflux in the prefrontal cortex in the light and dark period: effects of novelty and handling and comparison to the nucleus accumbens. Neuroscience. 100:741-748.
33. Finlay JM, Zigmond MJ, Abercrombie ED. 1995. Increased dopamine and norepinephrine release in medial prefrontal cortex induced by acute and chronic stress: effects of diazepam. Neuroscience. 64:619-628.
34. Goldstein LE, Rasmusson AM, Bunney BS, Roth RH. 1996. Role of the amygdala in the coordination of behavioral, neuroendocrine, and prefrontal cortical monoamine responses to psychological stress in the rat. J Neurosci. 16:4787-4798.
35. Grappi S, Nanni G, Leggio B, Rauggi R, Scheggi S, Masi F, Gambarana C. 2003. The efficacy of reboxetine in preventing and reverting a condition of escape deficit in rats. Biol Psychiatry. 53:890-898.
36. Hasler G, Drevets WC, Manji HK, Charney DS. 2004. Discovering endophenotypes for major depression. Neuropsychopharmacology. 29:1765-1781.
37. Herman JP, Figueiredo H, Mueller NK, Ulrich-Lai Y, Ostrander MM, Choi DC, Cullinan WE. 2003. Central mechanisms of stress integration: hierarchical circuitry controlling hypothalamo-pituitary-adrenocortical responsiveness. Front Neuroendocrinol. 24:151-180.
38. Hughes ZA, Stanford SC. 1998. A partial noradrenergic lesion induced by DSP-4 increases extracellular noradrenaline concentration in rat frontal cortex: a microdialysis study in vivo. Psychopharmacology (Berl). 136:299-303.
39. Imperato A, Angelucci L, Casolini P, Zocchi A, Puglisi-Allegra S. 1992. Repeated stressful experiences differently affect limbic dopamine release during and following stress. Brain Res. 577:194-199.
40. Imperato A, Cabib S, Puglisi-Allegra S. 1993. Repeated stressful experiences differently affect the time-dependent responses of the mesolimbic dopamine system to the stressor. Brain Res. 601:333-336.
41. Imperato A, Mele A, Scrocco MG, Puglisi-Allegra S. 1992. Chronic cocaine alters limbic extracellular dopamine. Neurochemical basis for addiction. Eur J Pharmacol. 212:299-300.
42. Imperato A, Puglisi-Allegra S, Casolini P, Angelucci L. 1991. Changes in brain dopamine and acetylcholine release during and following stress are independent of the pituitary-adrenocortical axis. Brain Res. 538:111-117.
43. Jedema HP, Sved AF, Zigmond MJ, Finlay JM. 1999. Sensitization of norepinephrine release in medial prefrontal cortex: effect of different chronic stress protocols. Brain Res. 830:211-217.
44. Kalivas PW, Volkow ND. 2005. The neural basis of addiction: a pathology of motivation and choice. Am J Psychiatry. 162:1403-1413.
45. Kawahara Y, Kawahara H, Westerink BH. 1999. Comparison of effects of hypotension and handling stress on the release of noradrenaline and dopamine in the locus coeruleus and medial prefrontal cortex of the rat. Naunyn Schmiedebergs Arch Pharmacol. 360:42-49.
46. Kelley AE. 2004. Memory and addiction: shared neural circuitry and molecular mechanisms. Neuron. 44:161-179.
47. King D, Zigmond MJ, Finlay JM. 1997. Effects of dopamine depletion in the medial prefrontal cortex on the stress-induced increase in extracellular dopamine in the nucleus accumbens core and shell. Neuroscience. 77:141-153.
48. Laruelle M. 2000. The role of endogenous sensitization in the pathophysiology of schizophrenia: implications from recent brain imaging studies. Brain Res Brain Res Rev. 31:371-384.
49. Lieberman JA, Perkins D, Belger A, Chakos M, Jarskog F, Boteva K, Gilmore J. 2001. The early stages of schizophrenia: speculations on pathogenesis, pathophysiology, and therapeutic approaches. Biol Psychiatry. 50:884-897.
50. Linner L, Wiker C, Wadenberg ML, Schalling M, Svensson TH. 2002. Noradrenaline reuptake inhibition enhances the antipsychotic-like effect of raclopride and potentiates D2-blockage-induced dopamine release in the medial prefrontal cortex of the rat. Neuropsychopharmacology. 27:691-698.
51. Lu L, Shepard JD, Scott Hall F, Shaham Y. 2003. Effect of environmental stressors on opiate and psychostimulant reinforcement, reinstatement and discrimination in rats: a review. Neurosci Biobehav Rev. 27:457-491.
52. Maier SF, Watkins LR. 2005. Stressor controllability and learned helplessness: the roles of the dorsal raphe nucleus, serotonin, and corticotropin-releasing factor. Neurosci Biobehav Rev. 29:829-841.
53. Marinelli M, Piazza PV. 2002. Interaction between glucocorticoid hormones, stress and psychostimulant drugs. Eur J Neurosci. 16:387-394.
54. McFarland K, Davidge SB, Lapish CC, Kalivas PW. 2004. Limbic and motor circuitry underlying footshock-induced reinstatement of cocaine-seeking behavior. J Neurosci. 24:1551-1560.
55. McQuade R, Creton D, Stanford SC. 1999. Effect of novel environmental stimuli on rat behaviour and central noradrenaline function measured by in vivo microdialysis. Psychopharmacology (Berl). 145:393-400.
56. Montezinho LP, Castro MM, Duarte CB, Penschuck S, Geraldes CF, Mork A. 2006. The interaction between dopamine D2-like and beta-adrenergic receptors in the prefrontal cortex is altered by moodstabilizing agents. J Neurochem. 96:1336-1348.
57. Morilak DA, Barrera G, Echevarria DJ, Garcia AS, Hernandez A, Ma S, Petre CO. 2005. Role of brain norepinephrine in the behavioral response to stress. Prog Neuropsychopharmacol Biol Psychiatry. 29:1214-1224.
58. Omelchenko N, Sesack SR. 2005. Laterodorsal tegmental projections to identified cell populations in the rat ventral tegmental area. J Comp Neurol. 483:217-235.
59. Page ME, Lucki I. 2002. Effects of acute and chronic reboxetine treatment on stress-induced monoamine efflux in the rat frontal cortex. Neuropsychopharmacology. 27:237-247.
60. Pan WH, Yang SY, Lin SK. 2004. Neurochemical interaction between dopaminergic and noradrenergic neurons in the medial prefrontal cortex. Synapse. 53:44-52.
61. Paxinos G, Watson C. 1998. The rat brain in stereotaxic coordinates. New York: Academic Press.
62. Puglisi-Allegra S, Imperato A, Angelucci L, Cabib S. 1991. Acute stress induces time-dependent responses in dopamine mesolimbic system. Brain Res. 554:217-222.
63. Ressler KJ, Nemeroff CB. 2001. Role of norepinephrine in the pathophysiology of neuropsychiatric disorders. CNS Spectr. 6:663-666, 670.
64. Robinson TE, Berridge KC. 2003. Addiction. Annu Rev Psychol. 54:25-53.
65. Rossetti ZL, Lai M, Hmaidan Y, Gessa GL. 1993. Depletion of mesolimbic dopamine during behavioral despair: partial reversal by chronic imipramine. Eur J Pharmacol. 242:313-315.
66. Salamone JD, Correa M, Mingote S, Weber SM. 2003. Nucleus accumbens dopamine and the regulation of effort in food-seeking behavior: implications for studies of natural motivation, psychiatry, and drug abuse. J Pharmacol Exp Ther. 305:1-8.
67. Salamone JD, Correa M, Mingote SM, Weber SM. 2005. Beyond the reward hypothesis: alternative functions of nucleus accumbens dopamine. Curr Opin Pharmacol. 5:34-41.
68. Sanchez CJ, Bailie TM, Wu WR, Li N, Sorg BA. 2003. Manipulation of dopamine d1-like receptor activation in the rat medial prefrontal cortex alters stress- and cocaine-induced reinstatement of conditioned place preference behavior. Neuroscience. 119:497-505.
69. Sesack SR, Carr DB. 2002. Selective prefrontal cortex inputs to dopamine cells: implications for schizophrenia. Physiol Behav. 77:513-517.
70. Shaham Y, Erb S, Stewart J. 2000. Stress-induced relapse to heroin and cocaine seeking in rats: a review. Brain Res Brain Res Rev. 33:13-33.
71. Stevenson CW, Gratton A. 2003. Basolateral amygdala modulation of the nucleus accumbens dopamine response to stress: role of the medial prefrontal cortex. Eur J Neurosci. 17:1287-1295.
72. Stewart J. 2004. Pathways to relapse: factors controlling the reinitiation of drug seeking after abstinence. Nebr Symp Motiv. 50:197-234.
73. Thierry AM, Tassin JP, Blanc G, Glowinski J. 1976. Selective activation of mesocortical DA system by stress. Nature. 263:242-244.
74. Toates F. 2004. Cognition, motivation, emotion and action: a dynamic and vulnerable interdependence. Appl Anim Behav Sci. 86:173-204.
75. Ursin H, Eriksen HR. 2004. The cognitive activation theory of stress. Psychoneuroendocrinology. 29:567-592.
76. Valentini V, Frau R, Di Chiara G. 2004. Noradrenaline transporter blockers raise extracellular dopamine in medial prefrontal but not parietal and occipital cortex: differences with mianserin and clozapine. J Neurochem. 88:917-927.
77. Ventura R, Alcaro A, Puglisi-Allegra S. 2005. Prefrontal cortical norepinephrine release is critical for morphine-induced reward, reinstatement and dopamine release in the nucleus accumbens. Cereb Cortex. 15:1877-1886.
78. Ventura R, Cabib S, Alcaro A, Orsini C, Puglisi-Allegra S. 2003. Norepinephrine in the prefrontal cortex is critical for amphetamine-induced reward and mesoaccumbens dopamine release. J Neurosci. 23:1879-1885.
79. Ventura R, Cabib S, Puglisi-Allegra S. 2002. Genetic susceptibility of mesocortical dopamine to stress determines liability to inhibition of mesoaccumbens dopamine and to behavioral 'despair' in a mouse model of depression. Neuroscience. 115:999-1007.
80. Vezina P. 2004. Sensitization of midbrain dopamine neuron reactivity and the self-administration of psychomotor stimulant drugs. Neurosci Biobehav Rev. 27:827-839.
81. Westerink BH, Enrico P, Feimann J, De Vries JB. 1998. The pharmacology of mesocortical dopamine neurons: a dual-probe microdialysis study in the ventral tegmental area and prefrontal cortex of the rat brain. J Pharmacol Exp Ther. 285:143-154.